erenumab (aimovig) is the first of four new migraine drugs in the pipeline that target calcitonin gene-related peptide (cgrp), a molecule that's produced in nerve cells of the
. 18 hours ago
.
.
one downside to existing drugs that prevent migraine is they can cause unpleasant side effects like
. and informal settlements. "this is far from the best start in life".
.
18 hours ago
.
.